These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 19782261

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S, Hoffmeister HM, Bode C.
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. High maintenance dosage of clopidogrel is associated with a reduced risk of stent thrombosis in clopidogrel-resistant patients.
    Tavassoli N, Voisin S, Carrie D, Lapeyre-Mestre M, Galinier M, Montastruc JL, Pathak A.
    Am J Cardiovasc Drugs; 2010 Jun; 10(1):29-35. PubMed ID: 20104932
    [Abstract] [Full Text] [Related]

  • 29. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
    Nienaber CA, Akin I, Schneider S, Senges J, Fetsch T, Tebbe U, Willich SN, Stumpf J, Sabin GV, Silber S, Richardt G, Kuck KH, DES.DE Study Group.
    Am J Cardiol; 2009 Nov 15; 104(10):1362-9. PubMed ID: 19892051
    [Abstract] [Full Text] [Related]

  • 30. Stent thrombosis with drug-eluting stents: a re-examination of the evidence.
    Kedia G, Lee MS.
    Catheter Cardiovasc Interv; 2007 May 01; 69(6):782-9. PubMed ID: 17394249
    [Abstract] [Full Text] [Related]

  • 31. Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries.
    Lasala JM, Cox DA, Dobies D, Baran K, Bachinsky WB, Rogers EW, Breall JA, Lewis DH, Song A, Starzyk RM, Mascioli SR, Dawkins KD, Baim DS, ARRIVE 1 and ARRIVE 2 Participating Physicians.
    Circ Cardiovasc Interv; 2009 Aug 01; 2(4):285-93. PubMed ID: 20031730
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The incidence and clinical predictors of early stent thrombosis in patients with acute coronary syndrome.
    Beinart R, Abu Sham'a R, Segev A, Hod H, Guetta V, Shechter M, Boyko V, Behar S, Matetzky S.
    Am Heart J; 2010 Jan 01; 159(1):118-24. PubMed ID: 20102877
    [Abstract] [Full Text] [Related]

  • 34. Antiplatelet therapy discontinuation following drug-eluting stent placement: dangers, reasons, and management recommendations.
    Moussa ID, Colombo A.
    Catheter Cardiovasc Interv; 2009 Dec 01; 74(7):1047-54. PubMed ID: 19626692
    [Abstract] [Full Text] [Related]

  • 35. [Drug-eluting stent thrombosis and its pharmacological prevention].
    Pershukov IV, Batyraliev TA.
    Kardiologiia; 2007 Dec 01; 47(7):60-7. PubMed ID: 18260897
    [Abstract] [Full Text] [Related]

  • 36. Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis.
    Pinto Slottow TL, Bonello L, Gavini R, Beauzile P, Sushinsky SJ, Scheinowitz M, Kaneshige K, Xue Z, Torguson R, Tantry U, Pichard AD, Satler LF, Suddath WO, Kent K, Gurbel P, Waksman R.
    Am J Cardiol; 2009 Aug 15; 104(4):525-30. PubMed ID: 19660606
    [Abstract] [Full Text] [Related]

  • 37. Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos).
    de la Torre-Hernández JM, Alfonso F, Hernández F, Elizaga J, Sanmartin M, Pinar E, Lozano I, Vazquez JM, Botas J, Perez de Prado A, Hernández JM, Sanchis J, Nodar JM, Gomez-Jaume A, Larman M, Diarte JA, Rodríguez-Collado J, Rumoroso JR, Lopez-Minguez JR, Mauri J, ESTROFA Study Group.
    J Am Coll Cardiol; 2008 Mar 11; 51(10):986-90. PubMed ID: 18325436
    [Abstract] [Full Text] [Related]

  • 38. Late thrombosis of paclitaxel-eluting stents: long-term incidence, clinical consequences, and risk factors in a cohort of 604 patients.
    Flores-Ríos X, Marzoa-Rivas R, Abugattás-de Torres JP, Piñón-Esteban P, Aldama-López G, Salgado-Fernández J, Calviño-Santos R, Vázquez-Rodríguez JM, Vázquez-González N, Castro-Beiras A.
    Am Heart J; 2008 Apr 11; 155(4):648-53. PubMed ID: 18371471
    [Abstract] [Full Text] [Related]

  • 39. Sirolimus-eluting cobalt-chromium stents: two-year clinical results from first-in-man study on the Firebird 2 stent.
    Xu B, Zhang Q, Yang YJ, Qiao SB, Zhang RY, Zhang JS, Hu J, Qin XW, Hong T, Li JP, Chen JL, Huo Y, Gao RL, Shen WF.
    Chin Med J (Engl); 2008 Mar 20; 121(6):492-7. PubMed ID: 18364131
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.